Transcriptic Stock

Transcriptic is a SaaS-based biotechnology company providing robotic solutions for biology labs.

Sign up today and learn more about Transcriptic Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Transcriptic Stock

Transcriptic is a new kind of scientific outsourcing provider. By expressing life science methods as data, infrastructure virtualization will become possible. "Science-as-a-Service" will power the next generation of discovery, driven by huge efficiencies of both time and money. Transcriptic was founded in 2012 to create a better way to get lab work done. Tired of spending endless hours at the bench pretending to be slow, error-prone robots, they set out to build a modern solution to the day-to-day process of wet lab biology. Drawing on deep computer science and electrical engineering backgrounds in addition to life science, Transcriptic was born: a meticulously optimized, technology-enabled remote lab. Using state-of-the-art automation and control technology, and an emphasis on user experience and usability, they are working on building a stark contrast to the long, complicated sales process, high prices, and slow turnarounds of traditional CROs. Molecular cloning is just the beginning. They are working hard to build a great company that can be a true partner for your lab for a long time, progressively enabling ever greater levels of productivity and efficiency. They are scientists building for scientists.

Funding History

November 2012$0
November 2012$1.2M
February 2014$2.8M
July 2014$1.8M
December 2014$120K
February 2015$8.5M
November 2016$13.4M

Management

Head of Scientific Operations

Yin He

Head of Sales

Ginger Cooper

VP of Engineering, Hardware

Jimmy Sastra

CEO

Yvonne Linney

Founder & Chief Executive Officer

Max Hodak

VP Engineering, Software

Evan Worley

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo